Schwartz B R, Pinkus G, Bacus S, Toder M, Weinberg D S
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Am J Pathol. 1989 Feb;134(2):327-36.
Ki-67 is a monoclonal antibody to a nuclear antigen present in cycling human cells but not in resting cells. The authors have performed immunoperoxidase on non-Hodgkin's lymphomas using Ki-67 antibody in order to correlate proliferation rates with tumor grade and type, and compare Ki-67 staining with S-phase content as determined by flow cytometry. Ki-67 staining of 109 sections was quantitated using a digital image analysis system (CAS 100). There was a significant difference among mean overall Ki-67 staining values in Working Formulation low (13.7%), intermediate (42.6%), and high grade tumors (57.9%, P less than 0.00001). The level of significance improved when a revised grading system was formulated based on proliferative activity, with the inclusion of diffuse large cell lymphomas in the high grade category. Within nodular and a few diffuse lymphomas, there were well-defined proliferation centers in which Ki-67 staining showed no correlation with grade. Flow cytometric DNA determination was performed on 74 specimens, and there was a positive correlation between Ki-67 positivity and S phase content (r = 0.66). It is concluded that Ki-67 staining of tissue sections is an alternative to flow cytometric quantitation of cell cycle activity in lymphomas, and provides the advantage of revealing histologic patterns of proliferation. By including G1 phase cells, Ki-67 staining allows a more complete determination of total cell cycle activity in lymphomas.
Ki-67是一种针对人类循环细胞中存在的核抗原的单克隆抗体,静止细胞中不存在该抗原。作者使用Ki-67抗体对非霍奇金淋巴瘤进行免疫过氧化物酶检测,以便将增殖率与肿瘤分级和类型相关联,并将Ki-67染色与通过流式细胞术测定的S期含量进行比较。使用数字图像分析系统(CAS 100)对109个切片的Ki-67染色进行定量。工作分类法中的低级别(13.7%)、中级别(42.6%)和高级别肿瘤(57.9%,P小于0.00001)的平均总体Ki-67染色值之间存在显著差异。当基于增殖活性制定修订的分级系统,将弥漫性大细胞淋巴瘤纳入高级别类别时,显著性水平有所提高。在结节性和少数弥漫性淋巴瘤中,存在明确的增殖中心,其中Ki-67染色与分级无关。对74个标本进行了流式细胞术DNA测定,Ki-67阳性与S期含量之间存在正相关(r = 0.66)。得出的结论是,组织切片的Ki-67染色是淋巴瘤细胞周期活性流式细胞术定量分析的一种替代方法,并且具有揭示增殖组织学模式的优势。通过纳入G1期细胞,Ki-67染色能够更全面地测定淋巴瘤中的总细胞周期活性。